These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 25932631)

  • 21. Structural basis of laminin binding to the LARGE glycans on dystroglycan.
    Briggs DC; Yoshida-Moriguchi T; Zheng T; Venzke D; Anderson ME; Strazzulli A; Moracci M; Yu L; Hohenester E; Campbell KP
    Nat Chem Biol; 2016 Oct; 12(10):810-4. PubMed ID: 27526028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Localization and functional analysis of the LARGE family of glycosyltransferases: significance for muscular dystrophy.
    Brockington M; Torelli S; Prandini P; Boito C; Dolatshad NF; Longman C; Brown SC; Muntoni F
    Hum Mol Genet; 2005 Mar; 14(5):657-65. PubMed ID: 15661757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Muscular dystrophy associated with alpha-dystroglycan deficiency in Sphynx and Devon Rex cats.
    Martin PT; Shelton GD; Dickinson PJ; Sturges BK; Xu R; LeCouteur RA; Guo LT; Grahn RA; Lo HP; North KN; Malik R; Engvall E; Lyons LA
    Neuromuscul Disord; 2008 Dec; 18(12):942-52. PubMed ID: 18990577
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ZZ domain of dystrophin and utrophin: topology and mapping of a beta-dystroglycan interaction site.
    Hnia K; Zouiten D; Cantel S; Chazalette D; Hugon G; Fehrentz JA; Masmoudi A; Diment A; Bramham J; Mornet D; Winder SJ
    Biochem J; 2007 Feb; 401(3):667-77. PubMed ID: 17009962
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aberrant glycosylation of alpha-dystroglycan causes defective binding of laminin in the muscle of chicken muscular dystrophy.
    Saito F; Blank M; Schröder J; Manya H; Shimizu T; Campbell KP; Endo T; Mizutani M; Kröger S; Matsumura K
    FEBS Lett; 2005 Apr; 579(11):2359-63. PubMed ID: 15848172
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutations in the human LARGE gene cause MDC1D, a novel form of congenital muscular dystrophy with severe mental retardation and abnormal glycosylation of alpha-dystroglycan.
    Longman C; Brockington M; Torelli S; Jimenez-Mallebrera C; Kennedy C; Khalil N; Feng L; Saran RK; Voit T; Merlini L; Sewry CA; Brown SC; Muntoni F
    Hum Mol Genet; 2003 Nov; 12(21):2853-61. PubMed ID: 12966029
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Defective glycosylation of α-dystroglycan contributes to podocyte flattening.
    Kojima K; Nosaka H; Kishimoto Y; Nishiyama Y; Fukuda S; Shimada M; Kodaka K; Saito F; Matsumura K; Shimizu T; Toda T; Takeda S; Kawachi H; Uchida S
    Kidney Int; 2011 Feb; 79(3):311-6. PubMed ID: 20944549
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Congenital mirror movements in a patient with alpha-dystroglycanopathy due to a novel POMK mutation.
    Ardicli D; Gocmen R; Talim B; Sprute R; Haliloglu G; Cirak S; Topaloglu H
    Neuromuscul Disord; 2017 Mar; 27(3):239-242. PubMed ID: 28109637
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exclusion of WWP1 mutations in a cohort of dystroglycanopathy patients.
    Godfrey C; Clement E; Abbs S; Muntoni F
    Muscle Nerve; 2011 Sep; 44(3):388-92. PubMed ID: 21996799
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autologous intramuscular transplantation of engineered satellite cells induces exosome-mediated systemic expression of Fukutin-related protein and rescues disease phenotype in a murine model of limb-girdle muscular dystrophy type 2I.
    Frattini P; Villa C; De Santis F; Meregalli M; Belicchi M; Erratico S; Bella P; Raimondi MT; Lu Q; Torrente Y
    Hum Mol Genet; 2017 Oct; 26(19):3682-3698. PubMed ID: 28666318
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure of the C-terminal laminin G-like domain pair of the laminin alpha2 chain harbouring binding sites for alpha-dystroglycan and heparin.
    Tisi D; Talts JF; Timpl R; Hohenester E
    EMBO J; 2000 Apr; 19(7):1432-40. PubMed ID: 10747011
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Defective glycosylation in muscular dystrophy.
    Muntoni F; Brockington M; Blake DJ; Torelli S; Brown SC
    Lancet; 2002 Nov; 360(9343):1419-21. PubMed ID: 12424008
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concerted mutation of Phe residues belonging to the beta-dystroglycan ectodomain strongly inhibits the interaction with alpha-dystroglycan in vitro.
    Bozzi M; Sciandra F; Ferri L; Torreri P; Pavoni E; Petrucci TC; Giardina B; Brancaccio A
    FEBS J; 2006 Nov; 273(21):4929-43. PubMed ID: 17018058
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aberrant glycosylation of alpha-dystroglycan and congenital muscular dystrophies.
    Endo T
    Acta Myol; 2005 Oct; 24(2):64-9. PubMed ID: 16550917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dystroglycanopathy: From Elucidation of Molecular and Pathological Mechanisms to Development of Treatment Methods.
    Kanagawa M
    Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884967
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Emerging novel therapeutic strategy for α-dystroglycanopathy by Large].
    Saito F
    Rinsho Shinkeigaku; 2011 Nov; 51(11):918-21. PubMed ID: 22277416
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carbohydrate-binding domain of the POMGnT1 stem region modulates O-mannosylation sites of α-dystroglycan.
    Kuwabara N; Manya H; Yamada T; Tateno H; Kanagawa M; Kobayashi K; Akasaka-Manya K; Hirose Y; Mizuno M; Ikeguchi M; Toda T; Hirabayashi J; Senda T; Endo T; Kato R
    Proc Natl Acad Sci U S A; 2016 Aug; 113(33):9280-5. PubMed ID: 27493216
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SEA domain proteolysis determines the functional composition of dystroglycan.
    Akhavan A; Crivelli SN; Singh M; Lingappa VR; Muschler JL
    FASEB J; 2008 Feb; 22(2):612-21. PubMed ID: 17905726
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation of enzyme activity and clinical phenotype in POMT1-associated dystroglycanopathies.
    Lommel M; Cirak S; Willer T; Hermann R; Uyanik G; van Bokhoven H; Körner C; Voit T; Barić I; Hehr U; Strahl S
    Neurology; 2010 Jan; 74(2):157-64. PubMed ID: 20065251
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impaired viability of muscle precursor cells in muscular dystrophy with glycosylation defects and amelioration of its severe phenotype by limited gene expression.
    Kanagawa M; Yu CC; Ito C; Fukada S; Hozoji-Inada M; Chiyo T; Kuga A; Matsuo M; Sato K; Yamaguchi M; Ito T; Ohtsuka Y; Katanosaka Y; Miyagoe-Suzuki Y; Naruse K; Kobayashi K; Okada T; Takeda S; Toda T
    Hum Mol Genet; 2013 Aug; 22(15):3003-15. PubMed ID: 23562821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.